Home/Pipeline/AUR-103

AUR-103

B‑cell malignancies

PreclinicalActive

Key Facts

Indication
B‑cell malignancies
Phase
Preclinical
Status
Active
Company

About Aurigene Pharmaceutical Services

Aurigene delivers AI‑enabled drug‑discovery services and a growing oncology pipeline for pharma partners.

View full company profile

Therapeutic Areas

Other B‑cell malignancies Drugs

DrugCompanyPhase
Rituximab (biosimilar)Laboratorio Elea PhoenixCommercial